Literature DB >> 28987708

Von Willebrand disease mutation spectrum and associated mutation mechanisms.

Annika de Jong1, Jeroen Eikenboom2.   

Abstract

Von Willebrand disease (VWD) is a bleeding disorder that is mainly caused by mutations in the multimeric protein von Willebrand factor (VWF). These mutations may lead to deficiencies in plasma VWF or dysfunctional VWF. VWF is a heterogeneous protein and over the past three decades, hundreds of VWF mutations have been identified. In this review we have organized all reported mutations, spanning a timeline from the late eighties until early 2017. This resulted in an overview of 750 unique mutations that are divided over the VWD types 1, 2A, 2B, 2M, 2N and 3. For many of these mutations the disease-causing effects have been characterized in vitro through expression studies, ex vivo by analysis of patient-derived endothelial cells, as well as in animal or (bio)physical models. Here we describe the mechanisms associated with the VWF mutations per VWD type.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hemostasis; Mutation mechanism; Mutation spectrum; Von Willebrand disease; Von Willebrand factor

Mesh:

Substances:

Year:  2017        PMID: 28987708     DOI: 10.1016/j.thromres.2017.09.025

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  20 in total

1.  Identification of von Willebrand factor D4 domain mutations in patients of Afro-Caribbean descent: In vitro characterization.

Authors:  Marie-Daniéla Dubois; Ivan Peyron; Olivier-Nicolas Pierre-Louis; Serge Pierre-Louis; Johalène Rabout; Pierre Boisseau; Annika de Jong; Sophie Susen; Jenny Goudemand; Rémi Neviere; Pascal Fuseau; Olivier D Christophe; Peter J Lenting; Cécile V Denis; Caterina Casari
Journal:  Res Pract Thromb Haemost       Date:  2022-06-15

Review 2.  New developments in von Willebrand disease.

Authors:  Helen Fogarty; Dearbhla Doherty; James S O'Donnell
Journal:  Br J Haematol       Date:  2020-05-12       Impact factor: 6.998

3.  Evidence for the Misfolding of the A1 Domain within Multimeric von Willebrand Factor in Type 2 von Willebrand Disease.

Authors:  Alexander Tischer; Maria A Brehm; Venkata R Machha; Laurie Moon-Tasson; Linda M Benson; Katelynn J Nelton; Rachel R Leger; Tobias Obser; Marina Martinez-Vargas; Steven T Whitten; Dong Chen; Rajiv K Pruthi; H Robert Bergen; Miguel A Cruz; Reinhard Schneppenheim; Matthew Auton
Journal:  J Mol Biol       Date:  2019-10-17       Impact factor: 5.469

4.  Von Willebrand disease type 2M: Correlation between genotype and phenotype.

Authors:  Dominique P M S M Maas; Ferdows Atiq; Nicole M A Blijlevens; Paul P T Brons; Sandy Krouwel; Britta A P Laros-van Gorkom; Frank W G Leebeek; Laurens Nieuwenhuizen; Selene C M Schoormans; Annet Simons; Daniëlle Meijer; Waander L van Heerde; Saskia E M Schols
Journal:  J Thromb Haemost       Date:  2021-11-21       Impact factor: 16.036

5.  Variability of von Willebrand factor-related parameters in endothelial colony forming cells.

Authors:  Annika de Jong; Ester Weijers; Richard Dirven; Suzan de Boer; Jasmin Streur; Jeroen Eikenboom
Journal:  J Thromb Haemost       Date:  2019-07-22       Impact factor: 5.824

6.  D' domain region Arg782-Cys799 of von Willebrand factor contributes to factor VIII binding.

Authors:  Małgorzata A Przeradzka; Josse van Galen; Eduard H T M Ebberink; Arie J Hoogendijk; Carmen van der Zwaan; Koen Mertens; Maartje van den Biggelaar; Alexander B Meijer
Journal:  Haematologica       Date:  2019-09-26       Impact factor: 9.941

7.  ADAMTS-13 and bleeding phenotype in von Willebrand disease.

Authors:  Johan Boender; Angelique Nederlof; Karina Meijer; Evelien P Mauser-Bunschoten; Marjon H Cnossen; Karin Fijnvandraat; Johanna G van der Bom; Joke de Meris; Britta A P Laros-van Gorkom; Karin P M van Galen; Jeroen Eikenboom; Moniek P M de Maat; Frank W G Leebeek
Journal:  Res Pract Thromb Haemost       Date:  2020-10-31

Review 8.  Genetics of equine bleeding disorders.

Authors:  Anna R Dahlgren; Fern Tablin; Carrie J Finno
Journal:  Equine Vet J       Date:  2020-06-23       Impact factor: 2.888

9.  Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.

Authors:  Luciano Baronciani; Ian Peake; Reinhard Schneppenheim; Anne Goodeve; Minoo Ahmadinejad; Zahra Badiee; Mohammad-Reza Baghaipour; Olga Benitez; Imre Bodó; Ulrich Budde; Andrea Cairo; Giancarlo Castaman; Peyman Eshghi; Jenny Goudemand; Wolf Hassenpflug; Hamid Hoorfar; Mehran Karimi; Bijan Keikhaei; Riitta Lassila; Frank W G Leebeek; Maria Fernanda Lopez Fernandez; Pier Mannuccio Mannucci; Renato Marino; Nikolas Nikšić; Florian Oyen; Cristina Santoro; Andreas Tiede; Gholamreza Toogeh; Alberto Tosetto; Marc Trossaert; Eva M K Zetterberg; Jeroen Eikenboom; Augusto B Federici; Flora Peyvandi
Journal:  Blood Adv       Date:  2021-08-10

Review 10.  How I manage severe von Willebrand disease.

Authors:  Frank W G Leebeek; Ferdows Atiq
Journal:  Br J Haematol       Date:  2019-09-09       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.